Aims The roles of implantable cardioverter-defibrillators (ICDs) and radiofrequency catheter
ablation (RCA) in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) and …

Objectives: This study sought to determine the long-term outcomes of catheter ablation (CA)
of ventricular tachycardia (VT) in a series of patients with arrhythmogenic right ventricular …

Aims The study aims to describe the long-term outcome of radiofrequency catheter ablation
for ventricular tachycardia (VT) in a large cohort arrhythmogenic right ventricular …

Background The pathologic process of ARVC (arrhythmogenic right ventricular
cardiomyopathy) typically originates in the epicardium or subepicardial layers with …

Aims Studies assessing radiofrequency ablation (RFA) of ventricular tachycardia (VT) in
arrhythmogenic right ventricular cardiomyopathy (ARVC) report VT recurrences, but have …

Background—Catheter ablation of ventricular tachycardia (VT) in arrhythmogenic right
ventricular cardiomyopathy improves short-term VT-free survival. We sought to determine …

Catheter ablation may reduce ventricular tachycardia (VT) burden in arrhythmogenic right
ventricular cardiomyopathy (ARVC) patients. However, little is known about factors …

Background Previous studies of radiofrequency catheter ablation (RFA) of ventricular
tachycardia (VT) in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) …

Aims To summarize our experience of radiofrequency catheter ablation (RFCA) for recurrent
drug-refractory ventricular tachycardias (VTs) due to arrhythmogenic right ventricular …

Aims Catheter ablation of ventricular tachycardia (VT) improves VT-free survival in 'classic'
arrhythmogenic right ventricular cardiomyopathy (ARVC). This study aimed to investigate the …